Skip to content
Recall Observatory FDA recall evidence

Drug product

Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product of India, Manufactured by: Cadila Healthcare Limited, Ahmadabad, India, Distributed by: Zydus Pharmaceuticals (USA ) Inc.m Pennington, NJ 08534, NDC 70710-1688-8.

D-1351-2022

July 15, 2022

Class II

Product summary

Firm
Zydus Pharmaceuticals (USA) Inc
Event
Event 90618
Status
Terminated
Classification
Class II
Quantity
1116 boxes
Official record key
drug-enforcement:D-1351-2022

Official wording

Reason: Failed Impurities/Degradation Specifications

Code information: Lot # B200076; Exp 31 JAN 2024

Distribution pattern: Nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications